Evidence map›Paper›PMID 24830344›Full record

ReviewNature reviews. Immunology2014

Positive and negative selection of the T cell repertoire: what thymocytes see (and don't see).

Ludger Klein, Bruno Kyewski, Paul M Allen, Kristin A Hogquist

Open access · greenAbstract readReview
In one paragraph

Review in Nature reviews. Immunology, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 819 papers.

0numbers the graph read from it
0cells of the map it votes in
819citing papers in PubMed
46.6field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

819 citing papers in PubMed, 1,321 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. Review
  5. Review
  6. Generation of effector CD4Stem cell reports · 2026
    Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. Review
  13. Article
  14. Article
  15. Review
  16. Decoding Spatial Heterogeneity and Multi-Omics Regulation with Hierarchical Graph Learning.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2026
    Article
  17. Review
  18. Review
  19. Article
  20. Article

759 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

4 authors at 3 institutions in 2 countries.

Ludger KleinInstitute for Immunology, Ludwig Maximilians University, 80336 Munich, Germany.
Bruno KyewskiDivision of Developmental Immunology, German Cancer Research Center, 69120 Heidelberg, Germany.
Paul M AllenDepartment of Pathology and Immunology, Washington University School of Medicine, St. Louis, Missouri 63110, USA.
Kristin A HogquistDepartment of Laboratory Medicine and Pathology, University of Minnesota, Minneapolis, Minnesota 55414, USA.
German Cancer Research Center · DELudwig-Maximilians-Universität München · DEWashington University in St. Louis · US

Funding

Type I interferons in tolerance in the steady stateP01AI035296 · NIAID · UNIVERSITY OF MINNESOTA TWIN CITIES · PI MUELLER, DANIEL L · 1993 to 2023
$31.1M
TCR signal strength in thymic selectionR37AI039560 · NIAID · UNIVERSITY OF MINNESOTA · PI HOGQUIST, KRISTIN A. · 2012 to 2021
$3.7M
T Cell Recognition of AntigenR37AI024157 · NIAID · WASHINGTON UNIVERSITY · PI ALLEN, PAUL M · 2002 to 2011
$3.5M
Peptide induction of positive selectionR01AI039560 · NIAID · UNIVERSITY OF MINNESOTA TWIN CITIES · PI HOGQUIST, KRISTIN A. · 2001 to 2010
$3.1M
RECOGNITION AND SIGNALING IN POSITIVE SELECTION OF CD4+ T CELLSR01AI024157 · NIAID · WASHINGTON UNIVERSITY · PI ALLEN, PAUL M · 1987 to 2016
$2.5M
Cortical epithelial cells in the selection and maturation of CD8 T cellsR01AI088209 · NIAID · UNIVERSITY OF MINNESOTA · PI HOGQUIST, KRISTIN A. · 2010 to 2014
$1.8M
Receptor editing in development T cellsR01AI050105 · NIAID · UNIVERSITY OF MINNESOTA TWIN CITIES · PI HOGQUIST, KRISTIN A. · 2003 to 2007
$1.4M
PEPTIDE INDUCTION OF POSITIVE SELECTIONR29AI039560 · NIAID · UNIVERSITY OF MINNESOTA TWIN CITIES · PI HOGQUIST, KRISTIN A. · 1996 to 2000
$111k
NIAID NIH HHS AI088209NIAID NIH HHS AI‑24157NIAID NIH HHS AI35296NIAID NIH HHS AI39560NIAID NIH HHS P01 AI035296NIAID NIH HHS R01 AI024157NIAID NIH HHS R01 AI039560NIAID NIH HHS R01 AI050105NIAID NIH HHS R01 AI088209NIAID NIH HHS R29 AI039560NIAID NIH HHS R37 AI024157NIAID NIH HHS R37 AI039560
6 · The paper itself

Abstract

The fate of developing T cells is specified by the interaction of their antigen receptors with self-peptide-MHC complexes that are displayed by thymic antigen-presenting cells (APCs). Various subsets of thymic APCs are strategically positioned in particular thymic microenvironments and they coordinate the selection of a functional and self-tolerant T cell repertoire. In this Review, we discuss the different strategies that these APCs use to sample and process self antigens and to thereby generate partly unique, 'idiosyncratic' peptide-MHC ligandomes. We discuss how the particular composition of the peptide-MHC ligandomes that are presented by specific APC subsets not only shapes the T cell repertoire in the thymus but may also indelibly imprint the behaviour of mature T cells in the periphery.

Indexed as

Immune ToleranceAnimalsAutoantigensB-LymphocytesCellular MicroenvironmentDendritic CellsHumansLymphopoiesisMiceReceptors, Antigen, T-CellThymocytesThymus GlandT-Lymphocytes, RegulatoryAutoantigensReceptors, Antigen, T-Cell

Identifiers

PMID24830344
PMCPMC4757912
OpenAlexW2024748688

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.